Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NLS-133 for Male Contraception
NCT07393334Phase 2Recruiting
- Sponsor
- Next Life Sciences
- Start
- Dec 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NLS-133 in male contraception, sponsored by Next Life Sciences. Started Dec 2025; status: recruiting.
02
Drugs
NLS-133
03
Conditions
male contraception
Beyond the preview
Go deeper on NCT07393334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07393334.